Nova Mentis Life Science Corp. (HN3Q.F)

0.0050 0.0000 (0.00%) As of 08:04AM CEST. Market open.

Nova Mentis Life Science Corp.

700-838 West Hasting Street
Vancouver, BC V6C 0A6
Canada
778-819-0244
https://www.novamentis.ca

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. William Rascan	President, CEO & Director	101.65k	N/A	1966
Ms. Rebecca Lynn Hudson C.A., CPA	Chief Financial Officer	48.79k	N/A	N/A
Mr. Derek Lloyd Harry Ivany	Executive Chairman	N/A	N/A	1983
Dr. Aylia Mohammadi B.Sc., M.Sc., Ph.D.	President & Chief Scientific Officer of Nova Mentis Biotech Corp.	24.4k	N/A	1980
Ms. Kelly Pladson	Corporate Secretary	N/A	N/A	1983

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Nova Mentis Life Science Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing diagnostics and psilocybin-based therapeutics for the treatment of neuroinflammatory disorders, including autism spectrum disorder and fragile X syndrome. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is based in Vancouver, Canada.

Corporate Governance

Nova Mentis Life Science Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.